{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:12:46Z","timestamp":1775322766080,"version":"3.50.1"},"reference-count":35,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,6,25]]},"DOI":"10.1253\/circj.cj-19-0148","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:04:04Z","timestamp":1559685844000},"page":"1498-1505","source":"Crossref","is-referenced-by-count":16,"title":["Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan"],"prefix":"10.1253","volume":"83","author":[{"given":"Satoshi","family":"Kodera","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arihiro","family":"Kiyosue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Ministry of Health, Labour and Welfare. Estimates of national medical care expenditure, FY 2016. https:\/\/www.mhlw.go.jp\/english\/database\/db-hss\/enmce_2016.html (accessed January 13, 2019)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. <i>Lancet<\/i> 2003; 361: 13\u201320.","DOI":"10.1016\/S0140-6736(03)12113-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. <i>N Engl J Med<\/i> 2014; 371: 1208\u20131217.","DOI":"10.1056\/NEJMoa1408758"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, et al. Five-year outcomes with PCI guided by fractional flow reserve. <i>N Engl J Med<\/i> 2018; 379: 250\u2013259.","DOI":"10.1056\/NEJMoa1803538"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Boden WE, O\u2019Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. <i>N Engl J Med<\/i> 2007; 356: 1503\u20131516.","DOI":"10.1056\/NEJMoa070829"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cohen DJ, Taira DA, Berezin R, Cox DA, Morice MC, Stone GW, et al. Cost-effectiveness of coronary stenting in acute myocardial infarction: Results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial. <i>Circulation<\/i> 2001; 104: 3039\u20133045.","DOI":"10.1161\/hc5001.100794"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Le May MR, Davies RF, Labinaz M, Sherrard H, Marquis JF, Laramee LA, et al. Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: Cost analysis of the Canadian STAT Study. <i>Circulation<\/i> 2003; 108: 2624\u20132630.","DOI":"10.1161\/01.CIR.0000097120.26062.FE"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, et al. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: Systematic review and economic evaluation. <i>Health Technol Assess<\/i> 2005; 9: 1\u201399, iii\u2013iv.","DOI":"10.3310\/hta9170"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bravo Vergel Y, Palmer S, Asseburg C, Fenwick E, de Belder M, Abrams K, et al. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis. <i>Heart<\/i> 2007; 93: 1238\u20131243.","DOI":"10.1136\/hrt.2006.111401"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, et al. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. <i>Circ Cardiovasc Qual Outcomes<\/i> 2008; 1: 12\u201320.","DOI":"10.1161\/CIRCOUTCOMES.108.798462"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hlatky MA, Boothroyd DB, Melsop KA, Kennedy L, Rihal C, Rogers WJ, et al. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. <i>Circulation<\/i> 2009; 120: 2550\u20132558.","DOI":"10.1161\/CIRCULATIONAHA.109.912709"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fearon WF, Shilane D, Pijls NH, Boothroyd DB, Tonino PA, Barbato E, et al. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. <i>Circulation<\/i> 2013; 128: 1335\u20131340.","DOI":"10.1161\/CIRCULATIONAHA.113.003059"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takura T, Tachibana K, Isshiki T, Sumitsuji S, Kuroda T, Mizote I, et al. Preliminary report on a cost-utility analysis of revascularization by percutaneous coronary intervention for ischemic heart disease. <i>Cardiovasc Interv Ther<\/i> 2017; 32: 127\u2013136.","DOI":"10.1007\/s12928-016-0401-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fearon WF, Nishi T, De Bruyne B, Boothroyd DB, Barbato E, Tonino P, et al. Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). <i>Circulation<\/i> 2018; 137: 480\u2013487.","DOI":"10.1161\/CIRCULATIONAHA.117.031907"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ishihara M, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, et al. Long-term outcomes of non-ST-elevation myocardial infarction without creatine kinase elevation: The J-MINUET Study. <i>Circ J<\/i> 2017; 81: 958\u2013965.","DOI":"10.1253\/circj.CJ-17-0033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanaka S, Sakata R, Marui A, Furukawa Y, Kita T, Kimura T. Predicting long-term mortality after first coronary revascularization: The Kyoto model. <i>Circ J<\/i> 2012; 76: 328\u2013334.","DOI":"10.1253\/circj.CJ-11-0398"},{"key":"17","unstructured":"17. Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: What is the threshold of cost effectiveness? <i>Health Econ<\/i> 2010; 19: 422\u2013437."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shiroiwa T, Fukuda T, Ikeda S, Takura T, Moriwaki K. Development of an official guideline for the economic evaluation of drugs\/medical devices in Japan. <i>Value Health<\/i> 2017; 20: 372\u2013378.","DOI":"10.1016\/j.jval.2016.08.726"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) \u2013 explanation and elaboration: A report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. <i>Value Health<\/i> 2013; 16: 231\u2013250.","DOI":"10.1016\/j.jval.2013.02.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kodera S, Morita H, Kiyosue A, Ando J, Komuro I. Cost-effectiveness of statin plus eicosapentaenoic acid combination therapy for cardiovascular disease prevention in Japanese patients with hypercholesterolemia: An analysis based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS). <i>Circ J<\/i> 2018; 82: 1076\u20131082.","DOI":"10.1253\/circj.CJ-17-0995"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kodera S, Morita H, Kiyosue A, Ando J, Takura T, Komuro I. Cost-effectiveness of PCSK9 inhibitor plus statin in patients with triple-vessel coronary artery disease in Japan. <i>Circ J<\/i> 2018; 82: 2602\u20132608.","DOI":"10.1253\/circj.CJ-17-1455"},{"key":"22","unstructured":"22. JCS Joint Working Group. Guidelines for the management of patients with ST-elevation acute myocardial infarction (JCS 2013). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2013_kimura_h.pdf (accessed January 13, 2019; in Japanese)."},{"key":"23","unstructured":"23. JCS Joint Working Group. Guidelines for elective percutaneous coronary intervention in patients with stable coronary disease (JCS 2011). http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2011_fujiwara_h.pdf (accessed January 13, 2019; in Japanese)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hattori N, Hirayama T, Katayama Y. Medical care for chronic-phase stroke in Japan. <i>Neurol Med Chir (Tokyo)<\/i> 2012; 52: 175\u2013180.","DOI":"10.2176\/nmc.52.175"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kamae I, Hashimoto Y, Koretsune Y, Tanahashi N, Murata T, Phatak H, et al. Cost-effectiveness analysis of apixaban against warfarin for stroke prevention in patients with nonvalvular atrial fibrillation in Japan. <i>Clin Ther<\/i> 2015; 37: 2837\u20132851.","DOI":"10.1016\/j.clinthera.2015.10.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matza LS, Stewart KD, Gandra SR, Delio PR, Fenster BE, Davies EW, et al. Acute and chronic impact of cardiovascular events on health state utilities. <i>BMC Health Serv Res<\/i> 2015; 15: 173.","DOI":"10.1186\/s12913-015-0772-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tanihata S, Nishigaki K, Kawasaki M, Takemura G, Minatoguchi S, Fujiwara H. Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP study 1-1. <i>Circ J<\/i> 2006; 70: 365\u2013369.","DOI":"10.1253\/circj.70.365"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Evans E, Imanaka Y, Sekimoto M, Ishizaki T, Hayashida K, Fukuda H, et al. Risk adjusted resource utilization for AMI patients treated in Japanese hospitals. <i>Health Econ<\/i> 2007; 16: 347\u2013359.","DOI":"10.1002\/hec.1177"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Park S, Lee J, Ikai H, Otsubo T, Imanaka Y. Decentralization and centralization of healthcare resources: Investigating the associations of hospital competition and number of cardiologists per hospital with mortality and resource utilization in Japan. <i>Health Policy<\/i> 2013; 113: 100\u2013109.","DOI":"10.1016\/j.healthpol.2013.06.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: Prevalence, cardiovascular event rates, and costs. <i>J Atheroscler Thromb<\/i> 2015; 22: 1287\u20131304.","DOI":"10.5551\/jat.28852"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, et al. Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: Report from the MIYAGI-AMI Registry Study. <i>Circ J<\/i> 2010; 74: 93\u2013100.","DOI":"10.1253\/circj.CJ-09-0619"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: A meta-analysis of individual patient data. <i>J Am Coll Cardiol<\/i> 2010; 55: 2435\u20132445.","DOI":"10.1016\/j.jacc.2010.03.007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kasai T, Miyauchi K, Kajimoto K, Kubota N, Kurata T, Daida H. Influence of diabetes on &gt;10-year outcomes after percutaneous coronary intervention. <i>Heart Vessels<\/i> 2008; 23: 149\u2013154.","DOI":"10.1007\/s00380-007-1021-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gada H, Kirtane AJ, Kereiakes DJ, Bangalore S, Moses JW, Genereux P, et al. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. <i>Am J Cardiol<\/i> 2015; 115: 1194\u20131199.","DOI":"10.1016\/j.amjcard.2015.01.556"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB Jr, Harrington RA, et al. Medical therapy with versus without revascularization in stable patients with moderate and severe ischemia: The case for community equipoise. <i>J Am Coll Cardiol<\/i> 2016; 67: 81\u201399.","DOI":"10.1016\/j.jacc.2015.09.056"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/7\/83_CJ-19-0148\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T03:18:12Z","timestamp":1561778292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/7\/83_CJ-19-0148\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0148","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]}}}